cilazapril, anhydrous has been researched along with Body Weight in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (17.65) | 18.7374 |
1990's | 12 (70.59) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartel, S; Hempel, P; Hoch, B; Karczewski, P | 1 |
Higashi, Y; Ishida, M; Ishida, T; Kambe, M; Miho, N; Nakashima, H; Ono, N; Oshima, T; Ozono, R; Yano, Y | 1 |
Deng, LY; Schiffrin, EL | 1 |
Anversa, P; Capasso, JM; Christe, ME; Li, P; Perretta, AA; Rodgers, RL | 1 |
Cook, NS; Hof, RP; Pally, C; Rudin, M; Zerwes, HG | 1 |
Ashida, T; Kawano, Y; Matsuoka, H; Omae, T; Yoshimi, H | 1 |
Li, JS; Schiffrin, EL; Sventek, P | 1 |
Cankurtaran, M; Kontaş, O; Müderris, II; Sahin, Y | 1 |
Abe, K; Isoyama, S; Nitta, Y; Tajima, M | 1 |
Hanatani, A; Iwao, H; Kim, S; Omura, T; Shimada, T; Shimizu, N; Takemoto, Y; Takeuchi, K; Yoshikawa, J; Yoshiyama, M | 1 |
al-Hajri, DK; al-Qattan, KK; Safer, AM | 1 |
Kataoka, H; Makino, H; Mimura, Y; Ogura, T; Otsuka, F; Yamauchi, T | 1 |
Amemiya, T; Bhutto, IA | 1 |
Clozel, JP; Fischli, W; Hartemann, D; Saunier, C | 1 |
Clozel, JP; Hefti, F | 1 |
Brown, AN; Durnin, C; McEwen, J; Rajaguru, S; Walters, GE; Williams, PE | 1 |
Huysmans, FT; Kleinbloesem, CH; Kloke, HJ; Koene, RA; Sluiter, HE; Wetzels, JF | 1 |
1 trial(s) available for cilazapril, anhydrous and Body Weight
Article | Year |
---|---|
Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Body Weight; Calcium Channel Blockers; Cilazapril; Clinical Trials as Topic; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Middle Aged; Nitrendipine; Potassium; Pyridazines; Random Allocation | 1989 |
16 other study(ies) available for cilazapril, anhydrous and Body Weight
Article | Year |
---|---|
Hypertrophic phenotype of cardiac calcium/calmodulin-dependent protein kinase II is reversed by angiotensin converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Body Weight; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cilazapril; Genetic Predisposition to Disease; In Vitro Techniques; Isoenzymes; Male; Myocardium; Organ Size; Phenotype; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; Stroke; Transcription, Genetic | 2002 |
Effect of amlodipine and cilazapril treatment on platelet Ca2+ handling in spontaneously hypertensive rats.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Platelets; Blood Pressure; Body Weight; Calcium; Calcium Channel Blockers; Cilazapril; Cytosol; Heart Rate; Hypertension; Ionomycin; Male; Platelet Aggregation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thrombin | 2003 |
Effect of antihypertensive treatment on response to endothelin of resistance arteries of hypertensive rats.
Topics: Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Body Weight; Cilazapril; Dose-Response Relationship, Drug; Endothelins; Heart Rate; Hydralazine; Hypertension, Renovascular; In Vitro Techniques; Mesenteric Artery, Inferior; Metoprolol; Muscle, Smooth, Vascular; Norepinephrine; Rats; Rats, Sprague-Dawley; Renin | 1993 |
Cilazapril treatment depresses ventricular function in spontaneously hypertensive rats.
Topics: Aging; Animals; Blood Pressure; Body Weight; Cilazapril; Heart; Heart Ventricles; Hypertension; In Vitro Techniques; Male; Myocardial Contraction; Organ Size; Papillary Muscles; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Stress, Mechanical; Ventricular Function, Left | 1994 |
Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery balloon catheter injury in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Carotid Arteries; Carotid Artery Injuries; Catheterization; Cilazapril; Enalapril; Heart Rate; Histocytochemistry; Magnetic Resonance Imaging; Rats; Rats, Wistar; Tissue Fixation | 1993 |
Effects of dietary salt and angiotensin-converting enzyme inhibitor on ATP-driven Ca pump and Na/Ca exchange in aortic rings of Dahl rats.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Caffeine; Calcium-Transporting ATPases; Cilazapril; Heart; Heart Rate; Hypertension; In Vitro Techniques; Ion Transport; Kidney; Male; Muscle, Smooth, Vascular; Organ Size; Rats; Renin-Angiotensin System; Sodium; Sodium, Dietary; Vasoconstriction; Vasodilation | 1996 |
Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Body Weight; Calcium Channel Blockers; Cardiomegaly; Cilazapril; Desoxycorticosterone; Endothelin-1; Hypertension; NG-Nitroarginine Methyl Ester; Nifedipine; Organ Size; Rats; Rats, Sprague-Dawley; Renin | 1996 |
Effects of angiotensin converting enzyme inhibitor cilazapril and angiotensin II antagonist saralasin in ovarian hyperstimulation syndrome in the rabbit.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Ascitic Fluid; Body Weight; Chorionic Gonadotropin; Cilazapril; Estradiol; Female; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation; Progesterone; Rabbits; Saralasin | 1997 |
Attenuation of heat shock protein expression by coronary occlusion in hypertrophied hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Carrier Proteins; Cilazapril; Coronary Disease; Heat-Shock Proteins; HSC70 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Male; Myocardium; Organ Size; Rats; Rats, Wistar; RNA, Messenger; Time Factors | 1997 |
Effect of cilazapril on ventricular remodeling assessed by Doppler-echocardiographic assessment and cardiac gene expression.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Calcium-Transporting ATPases; Cilazapril; Collagen; Contractile Proteins; Echocardiography, Doppler; Heart; Heart Ventricles; Hemodynamics; Male; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; RNA, Messenger | 1998 |
Distention of the lateral intercellular spaces (LIS) in the proximal tubule cells of the non-stenosed kidney of the 2K-1C Goldblatt model of hypertension as evidence of pressure diuresis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Cilazapril; Extracellular Space; Hypertension, Renovascular; Kidney Tubules, Proximal; Male; Microscopy, Electron; Rats; Rats, Sprague-Dawley | 1998 |
Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats.
Topics: Acetylglucosaminidase; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Cilazapril; Creatinine; Heart Rate; Kidney Glomerulus; Platelet-Derived Growth Factor; Proliferating Cell Nuclear Antigen; Proteinuria; Rats; Rats, Inbred Dahl; Sclerosis; Tetrazoles; Transforming Growth Factor beta; Urine | 1998 |
Effects of cilazapril on the retinal vessels in spontaneously hypertensive rats: corrosion cast and scanning electron microscopic study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Basement Membrane; Blood Pressure; Body Weight; Cerebrovascular Disorders; Cilazapril; Corrosion Casting; Endothelium, Vascular; Hypertension; Male; Matched-Pair Analysis; Microscopy, Electron; Microscopy, Electron, Scanning; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Retinal Vessels; Time Factors | 1999 |
Effects of cilazapril, a novel angiotensin converting enzyme inhibitor, on the structure of pulmonary arteries of rats exposed to chronic hypoxia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cilazapril; Heart; Hemodynamics; Hypertrophy; Hypoxia; Organ Size; Pulmonary Artery; Pyridazines; Rats | 1991 |
Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Cilazapril; Coronary Circulation; Dipyridamole; Heart; Hypertension; Male; Organ Size; Pyridazines; Rats; Rats, Inbred SHR; Regional Blood Flow | 1988 |
A pharmacokinetic study of cilazapril in elderly and young volunteers.
Topics: Administration, Oral; Adolescent; Aged; Aged, 80 and over; Aging; Angiotensin-Converting Enzyme Inhibitors; Body Weight; Child; Cilazapril; Creatinine; Female; Half-Life; Humans; Male; Pyridazines | 1989 |